PPP1R12A Copy Number Is Associated with Clinical Outcomes of Stage III CRC Receiving Oxaliplatin-Based Chemotherapy

<div>Kaplan-Meier survival curves of patients with stage III, IIIB, and IIIC disease receiving oxaliplatin-based chemotherapy. (a) RFS in colon; (b) RFS in rectum. MRT: median recurrence time.</div>

Mediators of Inflammation

fig2

Figure 2

Figure 2: PPP1R12A Copy Number Is Associated with Clinical Outcomes of Stage III CRC Receiving Oxaliplatin-Based Chemotherapy 